Recorded Chinese product: 盐酸萘甲唑林滴鼻液盐酸萘甲唑林滴鼻液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 江苏云阳集团药业有限公司Chinese legal name: 江苏云阳集团药业有限公司
主要成分Active Ingredients
- 萘甲唑啉Naijia Zuolin
药物知识说明
萘甲唑啉是一种在国家药监局注册认定的药品。该药品含有萘甲唑啉-ccb5dbdd等成分。
该药品关联的活性成分包括：萘甲唑啉Naijia Zuolin。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：江苏云阳集团药业有限公司Chinese legal name: 江苏云阳集团药业有限公司。
您可以探索含有相同成分的其他药品：萘甲唑啉-ccb5dbdd成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 盐酸萘甲唑林滴鼻液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 萘甲唑啉Naijia Zuolin.
Manufacturers recorded for this product: 江苏云阳集团药业有限公司Chinese legal name: 江苏云阳集团药业有限公司.
Explore other medicines containing the same ingredient: 萘甲唑啉 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 盐酸萘甲唑林滴鼻液Recorded Chinese product: 盐酸萘甲唑林滴鼻液
- 规格Specification: 10ml10 mL
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 江苏云阳集团药业有限公司Chinese legal name: 江苏云阳集团药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H32020257
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H32020257
Manufacturer
Chinese legal name: 江苏云阳集团药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H32020257
生产企业
江苏云阳集团药业有限公司(国产)
适应症
本品用于过敏性及炎症性鼻充血、急慢性鼻炎。
用法用量
滴鼻。一次1-2滴，一日4-6次，每次间隔4小时以上，连续使用不得超过7日。
不良反应
1.滴药过频易致反跳性鼻充血，久用可致药物性鼻炎。|2.少数人有轻微烧灼感、针刺感、鼻黏膜干燥以及头痛、头晕、心率加快等反应。|3.罕见过敏反应。
禁忌
萎缩性鼻炎及鼻腔干燥者禁用。
注意事项
1.严格按推荐用量使用，用药间隔不少于4～6小时，连续使用不得超过7天，如需继续使用，应咨询医师。|2.本品仅供滴鼻，切忌口服。|3.孕妇、高血压、冠心病及甲状腺功能亢进患者慎用。|4.使用后应拧紧瓶盖，防止污染。|5.对本品过敏者禁用，过敏体质者慎用。|6.本品性状发生改变时禁止使用。|7.请将本品放在儿童不能接触的地方。|8.如正在使用其他药品，使用本品前请咨询医师或药师。
贮藏
遮光，密闭保存。
规格
10ml
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.